Pfizer, Tempus collaborate on cancer drug development
Mobi Health News
MARCH 2, 2023
The multinational pharma company will access Tempus' AI-enabled data library to further therapeutic development and advance its portfolio in oncology.
This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.
Mobi Health News
MARCH 2, 2023
The multinational pharma company will access Tempus' AI-enabled data library to further therapeutic development and advance its portfolio in oncology.
Mobi Health News
MAY 28, 2020
The company's drug development CRO, Covance, will integrate Medable's software to expand its decentralized trial capabilities.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Digital Health Global
JANUARY 10, 2024
As we look forward to an exhilarating 2024, we believe this partnership will pave the way for significant advancements in the field of drug R&D for the benefit of the patients,” explained Khai Pham, CEO of ThinkingNodeLife.ai Debiopharm’s main activities include drug development, drug manufacturing and digital health investment.
Digital Health Global
JANUARY 26, 2024
Under the program, Deliberate AI’s assessment tool for anxiety and depression, the AI-generated Clinical Outcome Assessment or AI-COA , will receive support to become a qualified drug development tool (DDT). Global experts have also expressed support for Deliberate AI’s innovative approach.
Mobi Health News
OCTOBER 4, 2022
The alliance will expand Sanofi's trek into tech-based drug discovery and development platforms.
Mobi Health News
JANUARY 31, 2023
Cough monitoring company C-mo Medical Solutions and sexual healthcare provider TBD Health also announced funding rounds.
FierceHealthIT
DECEMBER 11, 2020
Optum: Why COVID-19 could significantly change the drug development pipeline. Fri, 12/11/2020 - 12:12.
Mobi Health News
OCTOBER 1, 2020
Valo Health’s Opal Computational Platform uses machine learning, cloud computing and real-world data to assist in the drug discovery and development process.
FierceHealthIT
JANUARY 20, 2022
Fierce JPM Week: How 23andMe plans to harness its massive database to further its ambitions in drug development. Thu, 01/20/2022 - 17:06.
FierceHealthIT
JULY 11, 2019
Startup Medicare Advantage insurer Clover Health has launched a new drug development subsidiary called Clover Therapeutics.
FierceHealthIT
MAY 3, 2021
Optum: Why payers should be watching flurry of drug development activity around eczema. Mon, 05/03/2021 - 15:53.
ActiGraph
SEPTEMBER 23, 2021
Oncology is one of the most active and fastest growing areas of drug development research, outpacing other therapeutic areas in terms of study volume, complexity, cost, and duration.
ActiGraph
SEPTEMBER 23, 2021
Oncology is one of the most active and fastest growing areas of drug development research, outpacing other therapeutic areas in terms of study volume, complexity, cost, and duration.
Mobi Health News
DECEMBER 28, 2022
Drug development platform Quris raised another $9 million, and PharmStars is accepting applications for its accelerator cohort focused on women's health and health equity.
Mobi Health News
JULY 9, 2019
From streamlining operations to fine-tuning optimal treatments, the technology makes a business case for pharma.
Mobi Health News
JULY 10, 2019
Dubbed Clover Therapeutics, the unit's first project will be a partnership with Genentech targeting ocular diseases among senior populations.
Mobi Health News
APRIL 5, 2022
The multiyear agreement will focus on speeding clinical trials and drug development in oncology and nonalcoholic steatohepatitis.
Mobi Health News
MAY 19, 2022
They aim to bring down the period and costs for new drug development.
KevinMD
MARCH 14, 2019
An important part of advancing medical research and drug development is making participation in clinical trials easier and more inclusive. To develop treatments that work on men, women, and children of all ages and different ethnicities we need to have clinical trial data that represents our diverse population.
Mobi Health News
JULY 15, 2021
Also: Entos works to improve drug development after closing its Series A round and Castor plans to build out its decentralized clinical trial platform with a $45 million investment.
Digital Health Global
SEPTEMBER 19, 2023
Among these transformative innovations, artificial intelligence (AI ) stands out as a major force, reshaping the fields of drug discovery , drug development, clinical trials and patient care. The clinical trials phase represents a crucial turning point in drug development, but is often characterised by inefficiencies and delays.
Digital Health Global
FEBRUARY 19, 2024
This expansion mirrors a trend identified in an industry report jointly published by Biofourmis and HealthXL last year, predicting widespread adoption of digital endpoints by pharmaceutical companies in drug development programs by 2030.
ActiGraph
DECEMBER 27, 2021
During the recent Annual ASCO Meeting , thousands of cancer researchers and clinicians from across the globe joined together virtually to present and discuss the latest findings and breakthroughs in cancer research and care.
Healthcare IT Today
MAY 25, 2021
Curebase today announced $15M in Series A funding to continue developing its decentralized clinical trial software platform and virtual research site capabilities, powering research where any patient, anywhere, can be part of clinical trials at home and with their own doctor.
Digital Health Global
JANUARY 25, 2024
Biomarkers will help select patients whose cancer biologies are best suited to treatment with the right drug targeting the active disease mechanism. Debiopharm’s main activities include drug development, drug manufacturing and digital health investment.
Electronic Health Reporter
APRIL 8, 2022
Most people don’t realize that it can take up to 15 years and an average of $1 billion to $2 billion dollars just to get one drug developed, pass clinical trials and ultimately approved by […]. The article How Technology Is Improving Success Rates In Drug Clinical Trials appeared first on electronichealthreporter.com.
Mobi Health News
FEBRUARY 19, 2019
BGN Technologies, the technology transfer company of Ben-Gurion University (BGU), today unveiled an artificial intelligence (AI) platform for monitoring and predicting the progression of neurodegenerative diseases for the purpose of identifying markers for personalised patient care and improved drug development.
Digital Health Global
MARCH 30, 2023
The FDA has announced several guidelines and plans to hold at least one public meeting on digital health technologies (DHTs) to be used in drug clinical trials by the end of the year. Drug development process questions the reliability and accuracy of DHT products.
Healthcare IT Today
APRIL 14, 2022
Artificial intelligence (AI) holds great promise to dramatically improve clinical outcomes for patients, but in a perverse twist, AI algorithms that are used to improve drug development and support healthcare don’t just highlight social inequities — they may ultimately exacerbate them. A lingering […].
Healthcare IT Today
MARCH 1, 2024
In this video, he describes other ways that AI can make drug development more efficient. At the design stage, a drug company can run millions of simulations to determine where risks lie and what parameters are most promising.
Digital Health Global
JANUARY 9, 2024
The funding speaks to the global nature of pre-approval access and its increasing importance in the drug development process. “ Our mutual dedication to building new approaches to pharmaceutical drug development and patient care will help bring promising pre-approval medicine to patients around the world, faster and more equitably.
Digital Health Global
MARCH 2, 2023
As part of the partnership, SSI will expand Koneksa’s medical strategy division, especially in translational and clinical drug development. Koneksa clients gain access to a team of PhDs and MDs at SSI with expertise in drug development.
Healthcare IT Today
NOVEMBER 24, 2021
The companies are evolving in many ways, including stepping outside drug development to tryout digital treatments and using lessons from the COVID-19 pandemic to rethink production and clinical trials. Where are pharma companies investing their windfall profits?
hea!thcare innovation - Clinical IT
MAY 16, 2019
Real-world evidence has the potential to be especially valuable in a number of healthcare use cases
Digital Health Global
JUNE 13, 2023
We’re on a mission to revolutionize drug development in clinical trials by harnessing the power of our digital solutions with real-time, data-driven insights. “The utilization of evidence-based digital biomarkers is the key to transforming healthcare,” said Chris Benko, CEO, Koneksa. “We’re
Society for Participatory Medicine
FEBRUARY 1, 2023
The FDA issued a series of four patient-focused drug development (PFDD) guidance documents which outline how patient co-design needs to successfully happen. By the power vested in clinical research, the FDA now pronounces us patient and industry. You may now kiss the cancer survivor.
Mobi Health News
APRIL 20, 2018
BenevolentAI, a UK company using artificial intelligence for drug development, has raised $115 million in new funding, mostly from undisclosed investors in the United States. Existing backer Woodford Investment Management also participated in the round, which brings the company’s total funds raised to over $200 million.
ActiGraph
FEBRUARY 1, 2023
Drug development success rates have been on the decline since 2015. 1 The machinery of clinical development urgently needs some new oil. Compounded by the pandemic, trial success rates fell to a 10-year low in 2021, averaging only a 5% likelihood of successful progression through all phases.
ActiGraph
FEBRUARY 1, 2023
Drug development success rates have been on the decline since 2015. 1 The machinery of clinical development urgently needs some new oil. Compounded by the pandemic, trial success rates fell to a 10-year low in 2021, averaging only a 5% likelihood of successful progression through all phases.
Electronic Health Reporter
SEPTEMBER 17, 2020
As many know, the pharmaceutical industry is heavily regulated and specialized, with slow drug-development timelines, strict processes and quality requirements, and rigid silos. Illegal copying is prohibited. By Dimitar Karaivanov, CEO and co-founder, Kanbanize. Without a direct relationship with […].
Healthcare IT Today
JANUARY 23, 2024
He also said that the benefits go beyond doctors; for instance, care coordinators can be more efficient and AI can help drug development. Nair suggested that AI can make it easier to manage health care regulations, on which a hospital spends 8 million dollars a year on average.
Healthcare IT Today
MARCH 15, 2024
We’re already seeing the benefits of AI-infused research in pharmaceuticals and drug development. According to WEF , the largest ten pharmaceutical companies have either partnered with or acquired AI companies to make use of AI-assisted drug development and design.
Digital Health Global
JUNE 20, 2023
Founded in 2018 and supported from the outset by LallianSe, the life sciences integrator, BrainTale has developed and commercializes an accessible, reliable and clinically validated brain measurement digital platform solution for drug developers and physicians – neurologists, neuroradiologists and intensivists.
Digital Health Global
DECEMBER 5, 2023
Despite a history of drug development failures in the field, recent work provides reason for optimism, showing a possible therapeutic arsenal to limit disease progression at an early stage.
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content